MBrace Therapeutics

Acquisition, funding and merger involving MBrace Therapeutics.

• MBrace Therapeutics has just announced a $85 Million fundraising (posted on November 16 2023).

View the org chart displaying its 15 main executives

Most searched biographies at MBrace Therapeutics

• Isan Chen, Chief Executive Officer and Director
• Chris Lemasters, Director
• Carolyn Ng, Board Member

Popular executive movements at MBrace Therapeutics

• Steve Alley has joined the company as Chief Scientific Officer  (posted on March 6 2024).
• Christopher Lemasters has joined the company as Independent Director  (posted on November 16 2023).

Create your alert
to follow the executive moves at MBrace Therapeutics.

MBrace Therapeutics has 2,292 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by MBrace Therapeutics

Social media about MBrace Therapeutics

• MBrace Therapeutics on Wikipedia, Google News & Yahoo Finance
• MBrace Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Dianna Devore

Call MBrace Therapeutics at +1 442 ...

View the org chart

Register to receive your alert

Report an error